APG Asset Management N.V. Has $8.37 Million Stock Position in Align Technology, Inc. (NASDAQ:ALGN)

APG Asset Management N.V. grew its position in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 2,095.3% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 41,579 shares of the medical equipment provider's stock after buying an additional 39,685 shares during the period. APG Asset Management N.V. owned approximately 0.06% of Align Technology worth $8,372,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Nordea Investment Management AB lifted its stake in shares of Align Technology by 3.5% during the fourth quarter. Nordea Investment Management AB now owns 273,664 shares of the medical equipment provider's stock worth $56,870,000 after buying an additional 9,139 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in Align Technology by 119.6% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 169,641 shares of the medical equipment provider's stock worth $35,368,000 after buying an additional 92,407 shares during the last quarter. Swedbank AB boosted its holdings in shares of Align Technology by 25.0% in the fourth quarter. Swedbank AB now owns 486,267 shares of the medical equipment provider's stock valued at $101,392,000 after acquiring an additional 97,152 shares in the last quarter. Principal Securities Inc. boosted its position in shares of Align Technology by 34.5% in the 4th quarter. Principal Securities Inc. now owns 1,881 shares of the medical equipment provider's stock worth $392,000 after buying an additional 483 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its position in Align Technology by 1.2% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 7,799 shares of the medical equipment provider's stock valued at $1,626,000 after buying an additional 91 shares during the last quarter. 88.43% of the stock is currently owned by hedge funds and other institutional investors.

Align Technology Stock Performance

NASDAQ:ALGN traded up $3.77 during mid-day trading on Wednesday, hitting $167.92. 318,292 shares of the company's stock traded hands, compared to its average volume of 866,999. Align Technology, Inc. has a twelve month low of $141.74 and a twelve month high of $327.49. The company has a market capitalization of $12.29 billion, a P/E ratio of 29.93, a P/E/G ratio of 2.24 and a beta of 1.73. The company has a fifty day moving average of $175.16 and a 200 day moving average of $206.13.

Align Technology (NASDAQ:ALGN - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $1.96 earnings per share for the quarter, missing analysts' consensus estimates of $2.43 by ($0.47). Align Technology had a net margin of 10.54% and a return on equity of 13.84%. On average, research analysts expect that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have weighed in on ALGN. Evercore ISI lifted their target price on Align Technology from $240.00 to $260.00 and gave the company an "outperform" rating in a research note on Thursday, February 6th. Needham & Company LLC reissued a "hold" rating on shares of Align Technology in a research report on Thursday, February 6th. Leerink Partnrs upgraded shares of Align Technology from a "hold" rating to a "strong-buy" rating in a report on Monday, January 6th. Wells Fargo & Company started coverage on Align Technology in a research note on Friday, February 14th. They issued an "overweight" rating and a $255.00 target price on the stock. Finally, Mizuho decreased their target price on shares of Align Technology from $295.00 to $250.00 and set an "outperform" rating for the company in a research note on Tuesday, March 25th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $256.90.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.